Literature DB >> 11162655

Cell-cycle dependent tyrosine phosphorylation on mortalin regulates its interaction with fibroblast growth factor-1.

E Mizukoshi1, M Suzuki, T Misono, A Loupatov, E Munekata, S C Kaul, R Wadhwa, T Imamura.   

Abstract

We previously reported that endogenously expressed, intracellularly localized fibroblast growth factor (FGF)-1 interacts with mortalin. Here we report that FGF-1 added to the culture medium of quiescent BALB/c3T3 cells is taken up by the cells and interacts with mortalin in the cells in a regulated manner. Although both the internalized FGF-1 and mortalin were present at high levels throughout the FGF-1-initiated cell cycle, their interaction became apparent only in late G1 phase. Interestingly, mortalin was preferentially tyrosine phosphorylated at the same time, and when its normally weak phosphorylation in early G1 phase was augmented by treating the cells with vanadate, a strong interaction between mortalin and FGF-1 was established. Conversely, when phosphorylated mortalin was treated with tyrosine phosphatase, its interaction with FGF-1 was abrogated. These results indicate that FGF-1 taken up by cells preferentially interacts with mortalin in late G1 phase of the cell cycle, and that tyrosine phosphorylation of mortalin regulates this interaction. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162655     DOI: 10.1006/bbrc.2001.4225

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60.

Authors:  Custer C Deocaris; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

Review 2.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

Authors:  Renu Wadhwa; Kazunari Taira; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

3.  Mortalin is Expressed by Astrocytes and Decreased in the Midbrain of Parkinson's Disease Patients.

Authors:  Travis J Cook; Jake G Hoekstra; David L Eaton; Jing Zhang
Journal:  Brain Pathol       Date:  2015-07-27       Impact factor: 6.508

4.  Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells.

Authors:  Sharath B Krishna; Lloyd F Alfonso; Thomas J Thekkumkara; Thomas J Abbruscato; G Jayarama Bhat
Journal:  Arch Biochem Biophys       Date:  2006-11-02       Impact factor: 4.013

5.  Sarcolipin retention in the endoplasmic reticulum depends on its C-terminal RSYQY sequence and its interaction with sarco(endo)plasmic Ca(2+)-ATPases.

Authors:  Anthony O Gramolini; Thomas Kislinger; Michio Asahi; Wenping Li; Andrew Emili; David H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

6.  Identification and functional characterization of nuclear mortalin in human carcinogenesis.

Authors:  Jihoon Ryu; Zeenia Kaul; A-Rum Yoon; Ye Liu; Tomoko Yaguchi; Youjin Na; Hyo Min Ahn; Ran Gao; Il-Kyu Choi; Chae-Ok Yun; Sunil C Kaul; Renu Wadhwa
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

Review 7.  AMPK: a cellular metabolic and redox sensor. A minireview.

Authors:  Najeeb A Shirwany; Ming-Hui Zou
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

8.  Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.

Authors:  Kirti Vaishnavi; Nishant Saxena; Navjot Shah; Rumani Singh; Kavyashree Manjunath; M Uthayakumar; Shankar P Kanaujia; Sunil C Kaul; Kanagaraj Sekar; Renu Wadhwa
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

9.  HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase.

Authors:  Jennifer Vomaske; Susan Varnum; Ryan Melnychuk; Patricia Smith; Ljiljana Pasa-Tolic; Janani I Shutthanandan; Daniel N Streblow
Journal:  Herpesviridae       Date:  2010-12-07

10.  HSP70s: From Tumor Transformation to Cancer Therapy.

Authors:  Chih-Wen Shu; Chun-Ming Huang
Journal:  Clin Med Oncol       Date:  2008-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.